The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Vol.
32
No.
1
January 30, 2009Jan 30, 2009
Free
DOWNLOAD THE PDF

Large Study Finds No Survival Benefit Associated With Removal Of Ovaries

ASCO Advises KRAS Testing In Patients With Metastatic Colorectal Cancer

Study Links Obesity To Higher Risk of Ovarian Cancer

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity

Early HER2 Positive Patients At Higher Risk of Recurrence

Tykerb Plus Letrozole Delayed Metastatic Breast Cancer

Estrogen Can Benefit Women With Metastatic Breast Cancer

Alternating Mammography, MRI Tested For High-Risk Women

Degarelix Approved For Advanced Prostate Cancer

NCI Cooperative Group, Cancer Center Trials Listed

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account